Wangjun Yan

2.0k total citations
86 papers, 1.3k citations indexed

About

Wangjun Yan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Wangjun Yan has authored 86 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 25 papers in Surgery. Recurrent topics in Wangjun Yan's work include Sarcoma Diagnosis and Treatment (36 papers), Bone Tumor Diagnosis and Treatments (17 papers) and Vascular Tumors and Angiosarcomas (11 papers). Wangjun Yan is often cited by papers focused on Sarcoma Diagnosis and Treatment (36 papers), Bone Tumor Diagnosis and Treatments (17 papers) and Vascular Tumors and Angiosarcomas (11 papers). Wangjun Yan collaborates with scholars based in China, United States and Japan. Wangjun Yan's co-authors include Xiangchun Zhang, Chunmeng Wang, Wending Huang, Weiluo Cai, Mo Cheng, Zhengwang Sun, Zhichao Zhang, Chung S. Yang, Yufeng He and Jinsong Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Wangjun Yan

80 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wangjun Yan China	20	337	324	318	291	281	86	1.3k
Min Dai China	22	175 0.5×	528 1.6×	460 1.4×	191 0.7×	256 0.9×	114	1.5k
Gang Xu China	24	265 0.8×	363 1.1×	419 1.3×	304 1.0×	150 0.5×	91	1.7k
Hideki Mizutani Japan	21	356 1.1×	683 2.1×	188 0.6×	432 1.5×	83 0.3×	81	1.9k
Zhengxue Quan China	20	143 0.4×	340 1.0×	462 1.5×	102 0.4×	418 1.5×	100	1.3k
Hai Zou China	21	137 0.4×	546 1.7×	107 0.3×	189 0.6×	111 0.4×	76	1.6k
Jingcheng Wang China	24	107 0.3×	458 1.4×	720 2.3×	128 0.4×	216 0.8×	105	1.9k
Yunsheng Ou China	20	220 0.7×	223 0.7×	423 1.3×	64 0.2×	248 0.9×	93	1.2k
Nan Jia China	22	193 0.6×	592 1.8×	185 0.6×	209 0.7×	119 0.4×	78	1.5k
Si̇nan Eki̇ci̇ Türkiye	19	407 1.2×	301 0.9×	371 1.2×	99 0.3×	76 0.3×	49	1.1k
Mohammad Amin Kerachian Iran	24	153 0.5×	752 2.3×	420 1.3×	448 1.5×	163 0.6×	86	1.8k

Countries citing papers authored by Wangjun Yan

Since Specialization

Citations

This map shows the geographic impact of Wangjun Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangjun Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangjun Yan more than expected).

Fields of papers citing papers by Wangjun Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangjun Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangjun Yan. The network helps show where Wangjun Yan may publish in the future.

Co-authorship network of co-authors of Wangjun Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Wangjun Yan. A scholar is included among the top collaborators of Wangjun Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangjun Yan. Wangjun Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Ting, Biqiang Zheng, Wangjun Yan, et al.. (2025). Fruquintinib as first‐line or second‐line treatment in unresectable or metastatic soft‐tissue sarcoma: A prospective, single‐arm phase II study. Clinical and Translational Medicine. 15(4). e70308–e70308. 1 indexed citations

Sun, Yangbai, et al.. (2025). Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?. Translational Cancer Research. 14(7). 4024–4033.

Cheng, Mo, Qing‐Jie Kong, Qing Tian, et al.. (2024). Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapy. Journal of Nanobiotechnology. 22(1). 151–151. 8 indexed citations

Wang, Ting, et al.. (2024). PARVB promotes malignant melanoma progression and is enhanced by hypoxic conditions. Translational Oncology. 42. 101861–101861.

Wang, Shuoer, Dongliang Wang, Kun Li, et al.. (2024). YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation. Cancer Letters. 597. 217047–217047. 12 indexed citations

Xu, Yu, Xin Lin, Wei Sun, et al.. (2023). 1173P NRAS mutation as an independent prognostic factor for resectable Chinese acral melanoma. Annals of Oncology. 34. S697–S697.

Cai, Weiluo, Mo Cheng, Yi Wang, et al.. (2023). Prediction and related genes of cancer distant metastasis based on deep learning. Computers in Biology and Medicine. 168. 107664–107664. 8 indexed citations

Fujiwara, Tomohiro, et al.. (2023). Does primary tumor resection improve survival for patients with sarcomas of pelvic bones, sacrum, and coccyx who have metastasis at diagnosis ?. European Spine Journal. 32(12). 4362–4376. 3 indexed citations

Sun, Wei, Yu Xu, Wangjun Yan, et al.. (2023). A real‐world study of adjuvant anti‐PD ‐1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations. Cancer Medicine. 12(15). 15945–15954. 7 indexed citations

10.

Wang, Bingnan, et al.. (2023). Establishment of a staging system for visceral sarcoma. Cancer Medicine. 13(1). e6791–e6791. 1 indexed citations

11.

Liang, Yimin, Chunmeng Wang, Shiyang Yu, et al.. (2023). IOX1 epigenetically enhanced photothermal therapy of 3D-printing silicene scaffolds against osteosarcoma with favorable bone regeneration. Materials Today Bio. 23. 100887–100887. 6 indexed citations

12.

Jiang, Shiyu, Xianghua Wu, Wangjun Yan, et al.. (2022). Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study. Clinical Cancer Research. 28(24). 5280–5289. 20 indexed citations

13.

Huang, Qiuyi, et al.. (2021). Novel Nomograms-Based Prediction Models for Patients with Primary Undifferentiated Pleomorphic Sarcomas Resections. Cancers. 13(8). 1917–1917. 5 indexed citations

14.

Wu, Zhiqiang, Wei Sun, Peng Luo, et al.. (2021). CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition. Frontiers in Oncology. 11. 687012–687012. 5 indexed citations

15.

Sun, Wei, Yu Xu, Jilong Yang, et al.. (2020). The prognostic significance of non‐sentinel lymph node metastasis in cutaneous and acral melanoma patients—A multicenter retrospective study. Cancer Communications. 40(11). 586–597. 6 indexed citations

16.

Yang, Xinghai, Jian Yang, Tong Meng, et al.. (2016). Surgical Consideration for Adolescents and Young Adults With Cervical Chordoma. Spine. 42(10). E609–E616. 12 indexed citations

17.

Ma, Yifei, Jun Pan, Wangjun Yan, et al.. (2016). Treatment options and prognosis for repeatedly recurrent giant cell tumor of the spine. European Spine Journal. 25(12). 4033–4042. 11 indexed citations

18.

Xiao, Hui, Tielong Liu, Wangjun Yan, et al.. (2014). The Valuation of Using FDG PET-CT in Detecting Osteoid Osteoma of the Cervical Spine. Journal of Spinal Disorders & Techniques. 28(2). E67–E73. 7 indexed citations

19.

Yang, Xinghai, Jianru Xiao, Zhipeng Wu, et al.. (2011). Anterior construction after resection for axis tumors through the sub mandible approach. Zhonghua guke zazhi. 31(6). 664–669. 1 indexed citations

20.

Shao, Jiang, Xiongsheng Chen, Lianshun Jia, et al.. (2011). Factors associated with early mortality after cervical spinal cord injury. Journal of Spinal Cord Medicine. 34(6). 555–562. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact